<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03153306</url>
  </required_header>
  <id_info>
    <org_study_id>HannanPH</org_study_id>
    <nct_id>NCT03153306</nct_id>
  </id_info>
  <brief_title>Importance of the Infusion Rate for the Plasma Expanding Effect of 5% Albumin in the Septic Patient</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hainan People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Southern Medical University, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hainan People's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Correction of hypovolemia is an important therapeutic measure，Even though there is no
      consensus regarding infusion rates, a plasma volume (PV) expander is often given at a fast
      rate to treat a suspected hypovolemia without delay which can be associated with aggravation
      of adverse interstitial accumulation of macromolecules and fluid, especially in inflammatory
      conditions such as sepsis.the smallest possible volumes for PV resuscitation to maintain
      normovolemia should be used to reduce the risk of simultaneous interstitial fluid
      accumulation. The investigators tested the hypothesis that a slow infusion rate of a PV
      expander results in better plasma expansion than a fast infusion rate to patients with severe
      sepsis or septic shock.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 2016</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Extravascular lung water (EVLW) before and after fluid resuscitation</measure>
    <time_frame>6 hour</time_frame>
    <description>Extravascular lung water （EVLW）is measured by Pulse index continous cardiac output (PICCO) before and after fluid resuscitation in each group</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>the &quot;bolus&quot; group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10ml/kg of the natural colloid 5% albumin was given at 1 hrs.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>the&quot;continuous&quot; group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10ml/kg of the natural colloid 5% albumin was given over 6 hrs</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>albumin</intervention_name>
    <description>Two groups were formed at random for each fluid. In one group, 10ml/kg of 5% albumin was given over 1 hour (the &quot;bolus&quot; group), and in the other group, the same volume was given over 6 hrs (the&quot;continuous&quot; group)</description>
    <arm_group_label>the &quot;bolus&quot; group</arm_group_label>
    <arm_group_label>the&quot;continuous&quot; group</arm_group_label>
    <other_name>human albumin(Austria)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  admitted to the ICU patients with severe sepsis or septic shock (diagnosis according
             to the 2012 surviving sepsis campaign guidelines)

          -  there is low blood pressure (SBP &lt; 90 or mean arterial pressure(MAP) &lt; 65 or the
             systolic blood pressure is decreased 40 mmHg more than the basic level) or lactic acid
             or greater for 4 mmol/l

          -  the informed consent

        Exclusion Criteria:

          -  less than 18 years of age

          -  more than 80 years old

          -  pregnant women

          -  albumin allergies

          -  the dying patients expected lifetime no more than 24 hours)

          -  patient with myocardial infarction, heart failure

          -  liver failure

          -  refused to sign the informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>rui li, PhD Candidate</last_name>
    <phone>18289559251</phone>
    <phone_ext>+86</phone_ext>
    <email>liruixxmc@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hainan Provincial People'S Hospital</name>
      <address>
        <city>Haikou</city>
        <state>Hainan</state>
        <zip>570000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>rui li, PhD Candidate</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 17, 2016</study_first_submitted>
  <study_first_submitted_qc>May 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2017</study_first_posted>
  <last_update_submitted>May 12, 2017</last_update_submitted>
  <last_update_submitted_qc>May 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hainan People's Hospital</investigator_affiliation>
    <investigator_full_name>rui li</investigator_full_name>
    <investigator_title>Attending Doctor, critical care medicine department</investigator_title>
  </responsible_party>
  <keyword>Albumin</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

